- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Japanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
5
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
5 companies
Ono Pharmaceutical
Market Cap: JP¥823.9b
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,754.00
7D
7.8%
1Y
-21.6%
Takeda Pharmaceutical
Market Cap: JP¥6.5t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,288.00
7D
9.0%
1Y
5.4%
Nippon Shinyaku
Market Cap: JP¥244.0b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,622.00
7D
5.7%
1Y
-13.9%
Seikagaku
Market Cap: JP¥37.4b
Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.
4548
JP¥685.00
7D
5.4%
1Y
-7.4%
Tsumura
Market Cap: JP¥334.2b
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
4540
JP¥4,400.00
7D
8.1%
1Y
16.5%